Related Experiment Video
Updated: Jun 27, 2026
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
New antimalarial and cytotoxic 4-nerolidylcatechol derivatives
Ana Cristina da Silva Pinto1, Luis Francisco Rocha Silva, Bruno Coelho Cavalcanti
1Universidade Federal do Amazonas, Campus Universitário, 69077-000 Manaus, AM, Brazil.
European Journal of Medicinal Chemistry
|December 17, 2008
Summary
Researchers developed new 4-nerolidylcatechol derivatives from Pothomorphe peltata root. These compounds show promise as stable, effective antimalarial drugs and anticancer agents, offering improved chemical and pharmacological properties.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- 4-Nerolidylcatechol (1) is a natural compound isolated from Pothomorphe peltata.
- Natural products often serve as scaffolds for drug development.
- The need for novel antimalarial and anticancer agents is critical.
Purpose of the Study:
- To synthesize novel semi-synthetic derivatives of 4-nerolidylcatechol.
- To evaluate the in vitro efficacy of these derivatives against multidrug-resistant Plasmodium falciparum.
- To assess the cytotoxic activity of the derivatives against human cancer cell lines.
Main Methods:
- Isolation of 4-nerolidylcatechol from Pothomorphe peltata root via solvent extraction and column chromatography.
- Preparation of semi-synthetic derivatives including mono-O-methyl, mono-O-benzyl, O,O-dibenzyl, and O,O-dibenzoyl ethers.
- In vitro testing against multidrug-resistant Plasmodium falciparum K1 strain and various human tumor cell lines.
Main Results:
- Several derivatives (2-8) demonstrated significant in vitro antimalarial activity with IC(50) values ranging from 0.67 to 22.52 microM.
- Mono-O-methyl ethers (6 and 7) exhibited potent inhibition against colon carcinoma, central nervous system, leukemia, and melanoma cell lines.
- The synthesized derivatives displayed enhanced stability to light, air, and pH compared to the natural precursor.
Conclusions:
- Semi-synthetic derivatives of 4-nerolidylcatechol possess promising antimalarial and anticancer properties.
- These derivatives represent a novel class of compounds with improved chemical and pharmacological profiles.
- The findings suggest potential for developing new therapeutic agents based on this scaffold.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...